CIK 0000093314
- Non-accelerated filer
- Smaller reporting company
VOLITIONRX LTD
Sign in to watch- Ticker
- VNRX
- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911949078
- Phone
- +1 512-774-8930
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Material agreement · Other events
- 4 Grant or award Group Chief Marketing Officer acquired 12,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 284 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 608 shares (to pay taxes)
- 8-K Event Unregistered share sale
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- S-3/A Offering Registration Statement
- SCHEDULE 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 8-K Event Unregistered share sale
- S-3 Offering Registration Statement
- 8-K Event Unregistered share sale
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 1 of 58 · 1,155 filings